Tandem Diabetes Care INC Form 4 insider transactions

Shannon Hansen, Chief Legal Officer of Tandem Diabetes Care, reports acquisition and disposal of company stock and derivative securities.

James Leal, Chief Manufacturing Officer of Tandem Diabetes Care, reports acquisition and disposal of company stock and restricted stock units on May 15, 2024.

CEO John F. Sheridan reports acquisition and disposal of Tandem Diabetes Care stock and vesting of restricted stock units.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

John F. Sheridan, President & CEO of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

EVP and CFO of Tandem Diabetes Care, Leigh Vosseller, reports the vesting of restricted stock units and subsequent tax withholding.

EVP and Chief Strategy Officer of Tandem Diabetes Care, Elizabeth Gasser, reports the vesting of restricted stock units and associated tax withholding.

James Leal, Chief Manufacturing Officer at Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.